CANCER – LIVER

 

Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma.                                                               (abst – 2006)  http://www.ncbi.nlm.nih.gov/pubmed/17074588

 

Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects      (abst – 2008)                                 http://gut.bmj.com/content/57/8/1140.abstract

 

 

Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma.                                                        (abst – 2009)  http://www.ncbi.nlm.nih.gov/pubmed/19059457

 

The synthetic cannabinoid WIN 55,212-2 sensitizes hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating p8/CCAAT/enhancer binding protein homologous protein (CHOP)/death receptor 5 (DR5) axis.  (full – 2010)    http://molpharm.aspetjournals.org/content/77/5/854.long

 

The effect of the activation of cannabinoid receptor on the proliferation and apoptosis of hepatoma HepG2 cells                                                        (abst – 2010)         http://www.ncbi.nlm.nih.gov/pubmed/20368112

 

Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells      (abst – 2010)                             http://www.ncbi.nlm.nih.gov/pubmed/20380798

 

Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK- dependent activation of autophagy.                                                            (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21475304

 

Cannabinoid receptor activation correlates with the pro-apoptotic action of the β2- adrenergic agonist, (R,R’)-4-methoxy-1-naphthylfenoterol, in HepG2 hepatocarcinoma cells.    (full – 2012)                          http://jpet.aspetjournals.org/content/early/2012/07/09/jpet.112.195206.long

 

Serum Metabolic Profiling Study of Hepatocellular Carcinoma Infected with Hepatitis B or Hepatitis C Virus by Using Liquid Chromatography-Mass Spectrometry.

(abst – 2012)                     http://www.ncbi.nlm.nih.gov/pubmed/22946841

 

Anti-proliferative effects of anandamide in human hepatocellular carcinoma cells. (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22970038

 

Evaluation of Anti-invasion Effect of Cannabinoids on Human Hepatocarcinoma Cells. (abst – 2012)                                            http://www.ncbi.nlm.nih.gov/pubmed/22978792

 

Study: Cannabis Agonists Produce Anti-Cancer Effects In Human Liver Cancer Cells (news – 2012)                                         http://norml.org/news/2012/10/11/study-cannabis-agonists-produce-anti-cancer-effects-  in-human-liver-cancer-cells

 

Anti-Cancer Effects In Human Liver Cancer Cells Produced By Cannabis Agonists (news – 2012)                                           http://www.imarijuana.com/tag/cannabinoid-agonists

 

Share a link for